Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis

EFFECTIVENESS OF SWITCHING FROM ORAL ZIPRASIDONE TO RISPERIDONE IN A PATIENT WITH COMORBID AUTISTIC DISORDER, PROFOUND INTELLECTUAL DISABILITY, GILBERT SYNDROME, AND EXACERBATION OF PSYCHOSIS Antonio Del Casale, Georgios D. Kotzalidis, Michele Sacco, Chiara Rapinesi, Riccardo De Giorgi, Marco Giardini, Michele D’Andreagiovanni, Nicola Carlino, Roberto Brugnoli & Paolo Girardi Department of Neurosciences, Mental Health, and Sensory Organs (NESMOS), School of Medicine and Psychology, Sapienza University; Unit of Psychiatry, Sant’Andrea Hospital, Rome, Italy Department of Psychiatric Rehabilitation, San Francesco Institute, P. Alberto Mileno Onlus Foundation, Vasto, CH, Italy Center for Outcomes Research and clinical Epidemiology (CORESEARCH), Pescara, Italy Department of Pathology, Foundation Year 2, Aberdeen Royal Infirmary (NHS Grampian), United Kingdom